A randomized, double-blind, phase III study assessing clinical similarity of SB17 (proposed ustekinumab biosimilar) to reference ustekinumab in subjects with moderate-to-severe plaque psoriasis.

Bibliographic Details
Published in:	Journal of the American Academy of Dermatology Vol. 91; no. 3; pp. 440 - 448
Main Authors:	Feldman, Steven R., Narbutt, Joanna, Girolomoni, Giampiero, Brzezicki, Jan, Reznichenko, Nataliya, Zegadło-Mylik, Maria Agnieszka, Pulka, Grazyna, Dmowska-Stecewicz, Magdalena, Kłujszo, Elżbieta, Rekalov, Dmytro, Rajzer, Lidia, Lee, Jiyoon, Lee, Minkyung, Rho, Young Hee
Format:	Journal Article
Published:	Elsevier B.V. Sep2024
Online Access:	View this record in EBSCOhost

Internet